Clinical Demand Target health systems and cardiac surgery centers focusing on preventing cardiorenal syndrome and acute kidney injury in high-risk cardiac surgery patients, leveraging Aortix as a percutaneous solution with ongoing pivotal IDE and reimbursement efforts.

Regulatory & Reimbursement Engage payer and hospital administration around CMS ICD-10-PCS procedure codes and Medicare reimbursement pathways already established, highlighting the technology’s potential to reduce complications and length of stay.

Strategic Partnerships Leverage recent board and executive appointments to open industry connections; pursue collaborations with prominent academic centers and major health systems for pivotal studies and real-world evidence generation.

Clinical Adoption Readiness Position Aortix as a preventive strategy for AKI and heart failure with renal impairment in surgery cohorts, aligning with care pathways and nephrology/cardiology specialties to accelerate enrollment in ongoing trials.

Funding & Growth Highlight substantial Series E funding and overall capital support to reassure growth trajectory, while targeting early adopters in mid-to-large hospitals that can drive scalable adoption and patient outcomes data.